Shlobin Nathan A, Wu Chengyuan
Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Department of Neurological Surgery, Thomas Jefferson University Hospitals, 909 Walnut Street, Floor 2, Philadelphia, PA, 19107, USA.
Curr Pain Headache Rep. 2023 Nov;27(11):719-728. doi: 10.1007/s11916-023-01168-5. Epub 2023 Sep 20.
PURPOSE OF REVIEW: Neurostimulation treatment options have become more commonly used for chronic pain conditions refractory to these options. In this review, we characterize current neurostimulation therapies for chronic pain conditions and provide an analysis of their effectiveness and clinical adoption. This manuscript will inform clinicians of treatment options for chronic pain. RECENT FINDINGS: Non-invasive neurostimulation includes transcranial direct current stimulation and repetitive transcranial magnetic stimulation, while more invasive options include spinal cord stimulation (SCS), peripheral nerve stimulation (PNS), dorsal root ganglion stimulation, motor cortex stimulation, and deep brain stimulation. Developments in transcranial direct current stimulation, repetitive transcranial magnetic stimulation, spinal cord stimulation, and peripheral nerve stimulation render these modalities most promising for the alleviating chronic pain. Neurostimulation for chronic pain involves non-invasive and invasive modalities with varying efficacy. Well-designed randomized controlled trials are required to delineate the outcomes of neurostimulatory modalities more precisely.
Curr Pain Headache Rep. 2023-11
Lancet. 2021-5-29
J Neural Transm (Vienna). 2020-4
Eur J Neurol. 2016-10
Physiol Res. 2012
Ann Agric Environ Med. 2013
Neuromodulation. 2019-7-16
Neuromodulation. 2024-12
Health Technol Assess. 2018-11
Discov Med. 2012-7
Front Neurosci. 2023-5-11
Bioengineering (Basel). 2023-2-1
Curr Pain Headache Rep. 2023-1
Front Mol Neurosci. 2022-5-26